Skip to main content
OpenTrials
Completed

NCT Number: NCT00406432

A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects

The study was designed to assess the steady-state pharmacokinetic profile of paroxetine after 14 day repeated daily dosing of the controlled release tablet formulation (25 mg) in healthy Chinese subjects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depressive Disorder Mental Disorders Mood Disorders

Age range

19 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

GSK Investigational Site

Beijing, 100730, China

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 19-45 years healthy Chinese subjects
  • Body weight > 50 kg
  • BMI between 19-25
  • serological negative for HIV, syphilis and hepatitis B and C
  • no abnormalities in ECG
  • Female with negative pregnancy and male has no plan to have a child during and 3 months after the study.

Exclusion criteria

  • History of chronic physical/mental disease, current disease and concomitant medication

Treatment and study plan

Paroxetine controlled release tablet

Drug

Eligible subjects will receive paroxetine controlled release tablet with dose of 25 milligrams.

Primary outcomes

  1. pharmacokinetic parameters

    Time frame: Up to 21 days

Secondary outcomes

  1. safety parameters(adverse events, lab test results,vital signs,electrocardiograph)

    Time frame: Up to 21 days

Sponsors and collaborators

Lead sponsor

GlaxoSmithKline

Industry

Registry information

Official study title

A Steady-state Study to Assess the Pharmacokinetic Profile of Paroxetine After 14 Day Repeated Daily Dosing of the Controlled Release Paroxetine Tablet (25 mg) in Healthy Chinese Subjects

Important dates

Study start
2006
Primary completion
2006
Study completion
2006
First posted
Dec 4, 2006
Registry last updated
Sep 29, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.